Operating Lease, Right-of-Use Asset of ENANTA PHARMACEUTICALS INC from 01 Oct 2019 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
ENANTA PHARMACEUTICALS INC quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 01 Oct 2019 to 30 Sep 2025.
  • ENANTA PHARMACEUTICALS INC Operating Lease, Right-of-Use Asset for the quarter ending 30 Sep 2025 was $37,549,000, a 7.6% decline year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

ENANTA PHARMACEUTICALS INC Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $37,549,000 -$3,109,000 -7.6% 30 Sep 2025 10-K 19 Nov 2025 2025 FY
Q2 2025 $38,250,000 -$2,961,000 -7.2% 30 Jun 2025 10-Q 13 Aug 2025 2025 Q3
Q1 2025 $39,103,000 -$3,791,000 -8.8% 31 Mar 2025 10-Q 14 May 2025 2025 Q2
Q4 2024 $39,675,000 +$18,331,000 +86% 31 Dec 2024 10-Q 12 Feb 2025 2024 Q1
Q3 2024 $40,658,000 +$17,864,000 +78% 30 Sep 2024 10-K 19 Nov 2025 2025 FY
Q2 2024 $41,211,000 +$17,243,000 +72% 30 Jun 2024 10-Q 07 Aug 2024 2024 Q3
Q1 2024 $42,894,000 +$18,340,000 +75% 31 Mar 2024 10-Q 08 May 2024 2024 Q2
Q4 2023 $21,344,000 -$2,196,000 -9.3% 31 Dec 2023 10-Q 08 Feb 2024 2024 Q1
Q3 2023 $22,794,000 -$781,000 -3.3% 30 Sep 2023 10-K 27 Nov 2024 2024 FY
Q2 2023 $23,968,000 +$475,000 +2% 30 Jun 2023 10-Q 08 Aug 2023 2023 Q3
Q1 2023 $24,554,000 +$7,338,000 +43% 31 Mar 2023 10-Q 09 May 2023 2023 Q2
Q4 2022 $23,540,000 +$4,706,000 +25% 31 Dec 2022 10-Q 08 Feb 2023 2023 Q1
Q3 2022 $23,575,000 +$18,864,000 +400% 30 Sep 2022 10-K 22 Nov 2023 2023 FY
Q2 2022 $23,493,000 +$17,576,000 +297% 30 Jun 2022 10-Q 08 Aug 2022 2022 Q3
Q1 2022 $17,216,000 +$10,244,000 +147% 31 Mar 2022 10-Q 09 May 2022 2022 Q2
Q4 2021 $18,834,000 +$11,059,000 +142% 31 Dec 2021 10-Q 10 Feb 2022 2022 Q1
Q3 2021 $4,711,000 -$2,309,000 -33% 30 Sep 2021 10-K 23 Nov 2022 2022 FY
Q2 2021 $5,917,000 -$1,728,000 -23% 30 Jun 2021 10-Q 09 Aug 2021 2021 Q3
Q1 2021 $6,972,000 -$865,000 -11% 31 Mar 2021 10-Q 10 May 2021 2021 Q2
Q4 2020 $7,775,000 +$13,000 +0.17% 31 Dec 2020 10-Q 09 Feb 2021 2021 Q1
Q3 2020 $7,020,000 -$1,602,000 -19% 30 Sep 2020 10-K 24 Nov 2021 2021 FY
Q2 2020 $7,645,000 30 Jun 2020 10-Q 10 Aug 2020 2020 Q3
Q1 2020 $7,837,000 31 Mar 2020 10-Q 11 May 2020 2020 Q2
Q4 2019 $7,762,000 31 Dec 2019 10-Q 10 Feb 2020 2020 Q1
Q3 2019 $8,622,000 01 Oct 2019 10-K 24 Nov 2021 2021 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.